Confluent director sells 1,074 shares in planned stock sale

Confluent, Inc. director reported an insider transaction in company stock.

Rhea-AI Filing Summary

Confluent, Inc. director reported an insider transaction in company stock. On 12/10/2025, the director sold 1,074 shares of Class A common stock at $30 per share, and after this trade beneficial ownership stood at 11,524 shares held directly.

The sale was executed under a pre-arranged 10b5-1 Plan dated September 12, 2024, which is designed to meet the affirmative defense conditions of Rule 10b5-1(c) for trading according to a preset plan.

Insider Trade Summary

Net Seller: 1,074 shares

Net Sell 1 txn

Insider Caimi Lara

Role Director

Sold 1,074 shs ($32K)

Type	Security	Shares	Price	Value
Sale	Class A Common Stock	1,074	$30.00	$32K

Holdings After Transaction: Class A Common Stock — 11,524 shares (Direct)

Footnotes (1)

1. F1. Shares were sold pursuant to a 10b5-1 Plan dated September 12, 2024.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Confluent (CFLT) report in this Form 4?

A Confluent, Inc. director reported selling 1,074 shares of Class A common stock on 12/10/2025.

At what price were the Confluent (CFLT) shares sold by the director?

The reported sale of Confluent Class A common stock was at a price of $30 per share.

How many Confluent (CFLT) shares does the director own after the reported sale?

Following the transaction, the director beneficially owned 11,524 shares of Confluent Class A common stock, held directly.

When did the reported Confluent (CFLT) insider transaction occur?

The insider transaction occurred on December 10, 2025, as the earliest transaction date.

Was the Confluent (CFLT) director’s share sale under a 10b5-1 trading plan?

Yes. The filing notes the shares were sold pursuant to a 10b5-1 Plan dated September 12, 2024, intended to meet Rule 10b5-1(c) conditions.

What is the reporting person’s relationship to Confluent (CFLT)?

The reporting person is identified as a Director of Confluent, Inc.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 12/12/2025 - 06:10 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Caimi Lara

(Last) (First) (Middle)

C/O CONFLUENT, INC.

899 W. EVELYN AVENUE

(Street)

MOUNTAIN VIEW CA 94041

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Confluent, Inc. [ CFLT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
12/10/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	12/10/2025		S		1,074(1)	D	$30	11,524	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Shares were sold pursuant to a 10b5-1 Plan dated September 12, 2024.

	/s/ Weilyn Wood, Attorney-in-Fact	12/12/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.